Carter Gould Analyst PerformanceBiopharma Equity Research at Cantor FitzgeraldCarter Gould is a stock analyst at Cantor Fitzgerald focused in the medical sector, covering 17 publicly traded companies. Over the past year, Carter Gould has issued 24 stock ratings, including buy and hold recommendations. While full access to Carter Gould's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Carter Gould's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings73 Last 9 YearsBuy Recommendations56.45% 35 Buy RatingsCompanies Covered17 Unique Companies Ratings Distribution62RatingsDistribution of strong buy, buy, hold, and sell ratings by Carter Gould.RatingPercentageCount Strong Buy0.0%0 ratings Buy56.5%35 ratings Hold38.7%24 ratings Sell4.8%3 ratingsOut of 62 total stock ratings issued by Carter Gould at Cantor Fitzgerald, the majority (56.5%) have been Buy recommendations, followed by 38.7% Hold and 4.8% Sell.Best & Worst CallsBest Call000.0%PCVXApr 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%ESPRJan 2018Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ64.7% of companies on NASDAQ11 companiesNYSE35.3% of companies on NYSE6 companiesCarter Gould, an analyst at Cantor Fitzgerald, currently covers 17 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical16 companies94.1%Computer and Technology1 company5.9%Carter Gould of Cantor Fitzgerald specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE11 companies64.7%LARGE CAP PHARMA4 companies23.5%COMP - SOFTWARE1 company5.9%MED - DRUGS1 company5.9% Carter Gould's Ratings History at Cantor Fitzgerald Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsLLYEli Lilly and Company5/1/2026Boost Price Target$970.57$1,230.00Overweight$0.0000.00% ROIABBVAbbVie4/30/2026Reiterated Rating$213.96$240.00Overweight$0.0000.00% ROIREGNRegeneron Pharmaceuticals4/23/2026Reiterated Rating$761.68$800.00Overweight$0.0000.00% ROIBMYBristol Myers Squibb4/8/2026Boost Price Target$57.68$54.00Neutral$0.0000.00% ROIAMGNAmgen4/8/2026Reiterated Rating$340.00$350.00Neutral$0.0000.00% ROIABBVAbbVie4/8/2026Lower Price Target$206.21$240.00Overweight$0.0000.00% ROIGILDGilead Sciences2/11/2026Boost Price Target$147.23$155.00Overweight$0.0000.00% ROILLYEli Lilly and Company2/5/2026Boost Price Target$1,037.98$1,205.00Overweight$0.0000.00% ROIPFEPfizer2/4/2026Reiterated Rating$26.73$27.00Neutral$0.0000.00% ROIMRKMerck & Co., Inc.2/4/2026Boost Price Target$119.84$120.00Neutral$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. AMGNAmgen2/4/2026Boost Price Target$364.01$350.00Neutral$0.0000.00% ROIREGNRegeneron Pharmaceuticals2/2/2026Boost Price Target$758.49$800.00Overweight$0.0000.00% ROIPFEPfizer1/27/2026Boost Price Target$25.87$27.00Neutral$0.0000.00% ROILLYEli Lilly and Company12/1/2025Reiterated Rating$1,069.22Overweight$0.0000.00% ROIAMGNAmgen11/6/2025Boost Price Target$314.03$315.00Neutral$0.0000.00% ROINUVLNuvalent10/31/2025Boost Price Target$98.17$112.00Overweight$0.0000.00% ROILLYEli Lilly and Company10/31/2025Boost Price Target$845.87$985.00Overweight$0.0000.00% ROIGILDGilead Sciences10/31/2025Reiterated Rating$120.76$135.00Overweight$0.0000.00% ROIREGNRegeneron Pharmaceuticals10/29/2025Boost Price Target$647.51$740.00Overweight$0.0000.00% ROILLYEli Lilly and Company10/9/2025Set Price Target$845.55$925.00Overweight$0.0000.00% ROIABBVAbbVie10/9/2025Set Price Target$231.26$250.00Overweight$0.0000.00% ROIABBVAbbVie9/15/2025Boost Price Target$218.40$245.00Overweight$0.0000.00% ROILLYEli Lilly and Company8/13/2025Lower Price Target$659.89$825.00Overweight$0.0000.00% ROIVRTXVertex Pharmaceuticals8/5/2025Lower Price Target$472.27$485.00Overweight$0.0000.00% ROICRMSalesforce4/23/2025Initiated Coverage$255.39$210.00Overweight$000.0000.00% ROIREGNRegeneron Pharmaceuticals4/22/2025Initiated Coverage$561.49$695.00Overweight$000.0000.00% ROIGILDGilead Sciences4/22/2025Initiated Coverage$104.33$125.00Overweight$000.0000.00% ROILLYEli Lilly and Company4/22/2025Initiated Coverage$818.18$975.00Overweight$000.0000.00% ROIVRTXVertex Pharmaceuticals4/22/2025Reiterated Rating$477.52$535.00Overweight$000.0000.00% ROIPFEPfizer4/22/2025Initiated Coverage$22.07$24.00Neutral$00.0000.00% ROIPCVXVaxcyte4/22/2025Initiated Coverage$30.39Overweight$00.0000.00% ROIMRKMerck & Co., Inc.4/22/2025Initiated Coverage$77.91$85.00Neutral$000.0000.00% ROIBMYBristol Myers Squibb4/22/2025Reiterated Rating$48.95$55.00Neutral$00.0000.00% ROIABBVAbbVie4/22/2025Initiated Coverage$170.01$210.00Overweight$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageRoyal Bank Of CanadaJPMorgan Chase & Co.Berenberg BankWall Street ZenUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyJefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel Nicolaus Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
